Open AccessP700: TREATMENT‐FREE REMISSION (TFR) AFTER DASATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML‐CP) AND DEEP MOLECULAR RESPONSE (DMR): FINAL 5‐YEAR RESULTS OF DASFREE
HemaspherePeer ReviewedShah N. P. +112022Journals
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support